Abbvie

ABBV13F as of Jun 30, 2026 · next update ~Nov 14

Who's buying ABBV

Top funds mostly trimmed Abbvie in Q2 (Apr⁠–⁠Jun)

Buying:

FundsInsidersCongress

Top funds
0 of 7 bought more, 5 sold some. Largest: Torray Investment Partners, $20.8M (3% of its portfolio).
Insiders
No buys, 4 sales in 12 months.
Congress
No buys, 4 sales in 12 months.

7 funds$50.0M held0.6% avg. weightQ2: 0 bought / 5 sold

13F reports are a snapshot as of Jun 30, 2026; funds may have traded since. Insiders often sell for personal reasons (taxes, diversification, planned sales).

Share price · market data, not from 13F reports

Q2 2026

Insider trades (Form 4)

Last 2 years · 15 filings

Date	Insider	Type	Shares	Price	Value
Aug 14, 2026	Nicholas Donoghoe VP	Sold	32,710	$250.00	$8.18M
Mar 4, 2026	David Ryan Purdue VP & Controller	Sold	5,230	$233.56	$1.22M
Mar 2, 2026	Perry C Siatis VP & Secretary	Sold	18,668	$234.39	$4.38M
Feb 25, 2026	Perry C Siatis VP & Secretary	Sold	22,381	$230.00	$5.15M
Aug 12, 2025	Azita Saleki-gerhardt VP	Sold	42,370	$198.42	$8.41M
Aug 5, 2025	Nicholas Donoghoe VP	Sold	13,295	$198.51	$2.64M
Mar 31, 2025	Jeffrey Ryan Stewart VP	Sold	58,832	$210.08	$12.36M
Mar 14, 2025	Scott T Reents VP & CFO	Sold	17,644	$212.34	$3.75M
Feb 28, 2025	Richard A Gonzalez Director	Sold	98,628	$205.45	$20.26M
Feb 28, 2025	Perry C Siatis VP & Secretary	Sold	27,900	$208.69	$5.82M
Mar 3, 2025	Timothy J. Richmond VP & CHRO	Sold	21,250	$210.45	$4.47M
Feb 26, 2025	Kevin K Buckbee VP & Controller	Sold	18,944	$203.41	$3.85M
Feb 26, 2025	Timothy J. Richmond VP & CHRO	Sold	29,917	$202.90	$6.07M
Feb 20, 2025	Perry C Siatis VP & Secretary	Sold	5,778	$197.90	$1.14M
Dec 16, 2024	Kevin K Buckbee VP & Controller	Sold	1,800	$172.24	$310K